Masoprocol
Masoprocol is an antineoplastic drug used to treat skin growths caused by sun exposure. A form of nordihydroguaiaretic acid that is taken by mouth is being studied in the treatment of prostate cancer.
Clinical data | |
---|---|
Trade names | Actinex |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Topical |
ATC code | |
Pharmacokinetic data | |
Bioavailability | Very low |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.044.172 |
Chemical and physical data | |
Formula | C18H22O4 |
Molar mass | 302.370 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Also called nordihydroguaiaretic acid, NDGA, and actinex.
Mechanism
Nordihydroguaiaretic acid is an antioxidant, and it may block certain enzymes needed for tumor growth.
It is a lipoxygenase inhibitor.[1]
References
- Gowri MS, Azhar RK, Kraemer FB, Reaven GM, Azhar S (September 2000). "Masoprocol decreases rat lipolytic activity by decreasing the phosphorylation of HSL". American Journal of Physiology. Endocrinology and Metabolism. 279 (3): E593-600. doi:10.1152/ajpendo.2000.279.3.E593. PMID 10950827.
External links
- MedlinePlus Drug Information
- Actinex entry in the public domain NCI Cancer Dictionary
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.